Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11

SIMPLE SUMMARY: Glioblastoma, IDH-wild type (GBM) is the most common malignant primary brain tumor. Advances in cancer therapy remain unsuccessful in the treatment of GBM patients and have not extended the median survival beyond 12–18 months with the current treatment of surgery, chemotherapy, and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tallman, Miranda M., Zalenski, Abigail A., Stabl, Ian, Schrock, Morgan S., Kollin, Luke, de Jong, Eliane, De, Kuntal, Grubb, Treg M., Summers, Matthew K., Venere, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296095/
https://www.ncbi.nlm.nih.gov/pubmed/37370783
http://dx.doi.org/10.3390/cancers15123173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296095/
https://www.ncbi.nlm.nih.gov/pubmed/37370783
http://dx.doi.org/10.3390/cancers15123173

Ejemplares similares